GR3036158T3 - Use of some glycosaminoglycans for the manufacture of a medicament for the treatment of chronic renal failure - Google Patents

Use of some glycosaminoglycans for the manufacture of a medicament for the treatment of chronic renal failure

Info

Publication number
GR3036158T3
GR3036158T3 GR20010401009T GR20010401009T GR3036158T3 GR 3036158 T3 GR3036158 T3 GR 3036158T3 GR 20010401009 T GR20010401009 T GR 20010401009T GR 20010401009 T GR20010401009 T GR 20010401009T GR 3036158 T3 GR3036158 T3 GR 3036158T3
Authority
GR
Greece
Prior art keywords
peritoneal
chronic renal
glycosaminoglycans
treatment
sulodexide
Prior art date
Application number
GR20010401009T
Other languages
English (en)
Inventor
Bruno Baggio
Giorgio Bazzato
Agostino Fracasso
Giovanni Gambaro
Egidio Marchi
Gianfranco Tamagnone
Original Assignee
Alfa Wassermann Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfa Wassermann Spa filed Critical Alfa Wassermann Spa
Publication of GR3036158T3 publication Critical patent/GR3036158T3/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37Digestive system
    • A61K35/38Stomach; Intestine; Goblet cells; Oral mucosa; Saliva
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727Heparin; Heparan
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Physiology (AREA)
  • Biomedical Technology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GR20010401009T 1994-10-06 2001-06-29 Use of some glycosaminoglycans for the manufacture of a medicament for the treatment of chronic renal failure GR3036158T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITBO940436A IT1274351B (it) 1994-10-06 1994-10-06 Uso di alcuni glicosaminoglicani nella dialisi peritoneale.

Publications (1)

Publication Number Publication Date
GR3036158T3 true GR3036158T3 (en) 2001-09-28

Family

ID=11340040

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20010401009T GR3036158T3 (en) 1994-10-06 2001-06-29 Use of some glycosaminoglycans for the manufacture of a medicament for the treatment of chronic renal failure

Country Status (9)

Country Link
US (1) US5686432A (el)
EP (1) EP0710483B1 (el)
AT (1) ATE202282T1 (el)
DE (1) DE69521388T2 (el)
DK (1) DK0710483T3 (el)
ES (1) ES2157277T3 (el)
GR (1) GR3036158T3 (el)
IT (1) IT1274351B (el)
PT (1) PT710483E (el)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL127896A0 (en) * 1998-12-31 1999-10-28 Gail Laster A novel treatment for preeclampsia and related diseases
JP2003504428A (ja) * 1999-06-30 2003-02-04 ハミルトン シビック ホスピタルズ リサーチ ディベロップメント インコーポレイテッド クロット関連凝固因子を阻害するヘパリン組成物
ITMI991503A1 (it) * 1999-07-08 2001-01-08 Bidifarm S R L Uso di metaboliti oligosaccaridici di proteoglicani come maker in fluidi biologici di diagnosi del biabete e delle complicanze patologiche c
US7259152B2 (en) * 2000-06-07 2007-08-21 Alfa Wasserman, Inc. Methods and compositions using sulodexide for the treatment of diabetic nephropathy
AU2001291549A1 (en) * 2000-09-08 2002-03-22 Hamilton Civic Hospitals Research Development Inc. Antithrombotic compositions
US20030008844A1 (en) * 2001-05-17 2003-01-09 Keryx Biopharmaceuticals, Inc. Use of sulodexide for the treatment of inflammatory bowel disease
US20030013680A1 (en) * 2001-06-12 2003-01-16 Keryx Methods using glycosaminoglycans for the treatment of nephropathy
PE20030263A1 (es) * 2001-07-31 2003-04-17 Novartis Ag Composicion farmaceutica oftalmica
EP1890686B1 (en) 2005-05-30 2017-10-04 Fresenius Medical Care Deutschland GmbH Peritoneal dialysis fluid
MX2008008213A (es) 2005-12-22 2008-09-03 Neurochem Int Ltd Tratamiento de trastornos renales, nefropatia diabetica y dislipidemias.
US20070155672A1 (en) * 2006-01-05 2007-07-05 Markus Voges Sterilized peritoneal dialysis solutions containing heparin
WO2009044765A1 (ja) * 2007-10-01 2009-04-09 Seikagaku Corporation 新規な低分子化コンドロイチン硫酸およびその用途
CN101632686A (zh) * 2008-04-04 2010-01-27 马斯特里赫特大学 糖胺聚糖用于修复糖萼的用途
IT1401253B1 (it) 2010-04-23 2013-07-18 Uni Degli Studi Carlo Bo Urbino Uso del sulodexide per la riduzione delle metalloproteinasi di matrice.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1245907B (it) * 1991-05-17 1994-10-25 Alfa Wassermann Spa Uso dei glicosaminoglicani nel trattamento della nefropatia diabetica e della neuropatia diabetica.
IT1270846B (it) * 1993-05-10 1997-05-13 Alfa Wassermann Spa Uso di sulodexide e delle specialita' medicinali che lo contengono nel trattamento della nefropatia diabetica.
DE69429576T2 (de) * 1993-09-30 2002-08-22 Seikagaku Kogyo K.K., Tokio/Tokyo Dermatansulfatezusammensetzung als antithromotisches mittel

Also Published As

Publication number Publication date
PT710483E (pt) 2001-09-28
ITBO940436A1 (it) 1996-04-06
ITBO940436A0 (it) 1994-10-06
EP0710483B1 (en) 2001-06-20
US5686432A (en) 1997-11-11
DK0710483T3 (da) 2001-09-03
ATE202282T1 (de) 2001-07-15
IT1274351B (it) 1997-07-17
DE69521388D1 (de) 2001-07-26
DE69521388T2 (de) 2001-10-11
EP0710483A1 (en) 1996-05-08
ES2157277T3 (es) 2001-08-16

Similar Documents

Publication Publication Date Title
DK0710483T3 (da) Anvendelse af visse glycosaminoglycaner til fremstillingen af et lægemiddel til behandlingen af kronisk nyresvigt
Amyot et al. Myoglobin clearance and removal during continuous venovenous hemofiltration
Taylor et al. Erythropoietin and spontaneous platelet aggregation in haemodialysis patients
Man et al. Phosphate removal during hemodialysis, hemodiafiltration, and hemofiltration A reappraisal
von Lilien et al. Five years' experience with continuous ambulatory or continuous cycling peritoneal dialysis in children
EP0824698A4 (en) DEVICE AND METHOD FOR BIOSPECIFIC ELIMINATION OF HEPARIN
Edefonti et al. Dietary prescription based on estimated nitrogen balance during peritoneal dialysis
Kierdorf et al. Continuous treatment modalities in acute renal failure
Briglia et al. Acute renal failure in the intensive care unit: therapy overview, patient risk stratification, complications of renal replacement, and special circumstances
Bunchman et al. Treatment of vancomycin overdose using high-efficiency dialysis membranes
Bellomo et al. Management of acute renal failure in the critically ill with continuous venovenous hemodiafiltration
Moncrief et al. Continuous ambulatory peritoneal dialysis
Gross et al. Ceftizoxime elimination kinetics in continuous ambulatory peritoneal dialysis
Koup et al. Ceftriaxone pharmacokinetics during peritoneal dialysis
Davies et al. Failure Treated by Continuous Arteriovenous Haemodialysis
Schrader et al. Long-term intraperitoneal application of low molecular weight heparin in a continuous ambulatory peritoneal dialysis patient with deep vein thrombosis
Bosworth et al. Long-Term Experience with Continuous Renal Replacement Therapy in Intensive-Care Unit
Boelaert et al. Effect of renal function and dialysis on temocillin pharmacokinetics
Gotloib et al. Hemofiltration in severe septic adult respiratory distress syndrome associated with varicella
Sigler et al. Continuous Renal Replacement Therapy in the Critically III Patient With Acute Renal Failure: Pros and Cons
Vaziri Long-term haemodialysis in spinal cord injured patients
Von Herrath et al. Good biocompatibility of the polyamide hemofilter
Bosch et al. Reverse flux filtration: a new mode of therapy improving the efficacy of heparin-induced extracorporeal LDL precipitation in hyperlipidemic hemodialysis patients
Riambau et al. Sequential Intraperitoneal Adkinistration of Nitroprusside in Patients Yaintained on Peritoneal Dialysis
Sieberth Continuous Hemofiltration: 2nd International Conferenc, Baden/Austria, September 1990